Swapping one atom, remaking a drug's skeleton

The molecules that become medicines are, for the most part, built on rings: cyclic structures of atoms that form the rigid skeletons on which the rest of the molecule hangs, and the rings’ size and composition shape what a drug can do. Modifying those rings has always been one of chemistry’s most valuable and most difficult operations, because changing a ring’s atoms changes its geometry, its stability and its behaviour in the body. A paper in the 15 October issue of Nature reports a new general strategy for the operation at its most delicate: swapping one atom for another inside the saturated four-membered rings that sit at the core of countless bioactive molecules.

The four-membered ring is a chemist’s everyday obstacle and opportunity. Saturated four-membered rings, the cyclobutanes and their relatives, appear in the skeletons of numerous drugs and natural products, and the ability to replace one atom in such a ring, say a carbon for a nitrogen or an oxygen, would transform what can be made from them. The problem has been method: the rings are strained, the positions are specific, and the swap has to happen without destroying the structure around it. The new strategy, led by researchers at the National University of Singapore with collaborators in Hong Kong, provides a general route to the swap.

The significance of generality is hard to overstate in synthetic chemistry. Many reactions are demonstrated on one molecule and die there; a strategy is useful when it works across a family, tolerating the different substituents and variations that real drug discovery presents. The paper’s reported approach, the authors argue, offers exactly that breadth: a reliable way to exchange the atom at a chosen position in these rings, opening access to structures that were previously difficult or impossible to reach by other routes.

The downstream value is in the speed and shape of drug discovery. Medicinal chemists spend much of their time making close relatives of existing molecules, and the ability to swap an atom in a ring core shortens that work dramatically; a modification that once required a new synthetic route can become a single transformation. The result is not just convenience but coverage: compounds that were too costly to make are now within reach, and the molecules that can be tested against a biological target expand accordingly.

The paper is, at bottom, a piece of enabling science, the kind whose importance is measured in what other people do with it. It does not announce a new drug; it announces a new way of making the skeletons from which drugs are built. The significance of such enabling work is easy to understate precisely because its value is indirect: a reaction that saves a chemist weeks in one laboratory shows up, years later, as a molecule in a clinic, and by then the connection has become invisible. The ring structures at the heart of the pharmacopeia have gained a new tool for their modification, and the molecules of the future, made more cheaply and more variously, will carry the quiet signature of the atom swaps that this work made routine.